Long-term productive human cytomegalovirus infection of a human neuroblastoma cell line

International Journal of Cancer

Volumn 65, Issue 1, 1996, Pages 90-96

  Cinatl Jr , Jindrich ^a   Vogel, Jens U ^a   Cinatl, Jaroslav ^a   Weber, Bernard ^a   Rabenau, Holger ^a   Novak, Milos ^b   Kornhuber, Bernhard ^a   Doerr, Hans W ^a  

^a GOETHE UNIVERSITY   (Germany)

^b Clinical Laboratories Stresovice   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CULTURE; CONTROLLED STUDY; CYTOMEGALOVIRUS; HUMAN; HUMAN CELL; NEUROBLASTOMA; PRIORITY JOURNAL; TUMOR CELL LINE; VIRUS REPLICATION;

CELL DIFFERENTIATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DOPAMINE BETA-HYDROXYLASE; HUMANS; NEUROBLASTOMA; PROTO-ONCOGENE PROTEINS C-MYC; TUMOR CELLS, CULTURED; TYROSINE 3-MONOOXYGENASE; VIRUS REPLICATION;

EID: 0030064037     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960103)65:1<90::AID-IJC16>3.0.CO;2-M     Document Type: Article

References (24)

1. ALFORD, C.A. and BRITT, W.J., Cytomegalovirus. In: B.N. Fields, D.M. Knipe, R.M. Chanock, M.S. Hirsch, J.L. Melnick, T.P. Monath and B. Roizman (eds.) Fields virology (vol. 2), pp. 1981-2010, Raven Press, New York (1990).
2. ANDREWS, P.W., DAMJANOV, I., SLMON, D., BANTING, G.S., CARLIN, C., DRACOPOLI, N.C. and FOGH, J., Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2. Lab. Invest., 50, 147-162 (1984).
3. BOLDOGH, I., ABUBAKAR, S., DENG, C.Z. and AUBRECHT, T., Transcriptional activation of cellular oncogenes fos, jun, and myc by human cytomegalovirus. J. Virol., 65, 1568-1571 (1991).
4. BRODEUR, G.M., HAYES, A., GREEN, A., CASPER, J.T., WATSON, J. and SEEGER, R., Consistent N-myc copy number in simultaneous of consecutive NB samples from sixty individual patients. Cancer Res., 47, 4248-4253 (1987).
5. CICCARONE, V., SPENGLER, B.A., MEYERS, M.B., BIEDLER, J.L. and ROSS, R.A., Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages. Cancer Res., 49, 219-225 (1989).
6. CINATL, J., GUSSETIS, E.S., CINATL, J., JR., EBENER, U., MAINKE, M., SCHWABE, D., DOERR, H.W., KORNHUBER, B. and GEREIN, V. Differentiation arrest in neuroblastoma cell culture. J. Cancer Res. clin. Oncol. (Suppl.), 116, 9 (1990)
7. CINATL, J. JR., CINATL, J., RABENAU, H., GÜMBEL, H.O., KORNHUBER, B. and DOERR, H.W., In vitro inhibition of human cytomegalovirus replication of desferrioxamine. Antiviral Res., 25, 73-78 (1994a).
8. CINATL, J., JR., CINATL, J., RADSAK, K., RABENAU, H., WEBER, B., NOVAK, M., BENDA, R., KORNHUBER, B. and DOERR, H.W., Replication of human cytomegalovirus in a rhabdomyosarcoma cell line depends on the state of differentiation of the cells. Arch. Virol., 138, 391-401 (1994b).
9. DEHNER, L.P., Peripheral and central primitive neuroectodermal tumors. Arch. Pathol. lab. Med., 110, 997-1005 (1986).
10. FERRANDIS, E. DASILVA, J., RIOU, G. and BENARD, I., Coactivation of the MDR-1, MYCN genes in human neuroblastoma cells during the metastatic process in the nude mouse. Cancer Res., 54, 2256-2261 (1994).
11. FURUKAWA, T., A variant of human cytomegalovirus derived from a persistently infected culture. Virology, 137, 191-194 (1984).
12. GONCZOL, E., ANDREWS, P.W. and PLOTKIN, S.A., Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science, 254, 156-161 (1984).
13. GRODY, W.W., LEWIN, K.J. and NAEIM, F., Detection of cytomegalovirus DNA in classic and epidemic Kaposi's sarcoma by in situ hybridization. Hum. Pathol., 19, 524-528 (1988).
14. MOLINOFF, P.B., WEINSHILBOUM, R. and AXELROD, J., A sensitive enzymatic assay for dopamine-βhydroxylase. J. Pharmacol. exp. Ther., 178, 425-431 (1971).
15. OGURA, T., TANAKA, J., KAMIYA, S., SATO, H., OGURA, H. and HATANO, M., Human cytomegalovirus persistent infection in a human central nervous system cell line: production of a variant virus with different growth characteristics. J. gen. Virol., 67, 2605-2616 (1986).
16. POLAND, S.D., COSTELLO, P., DEKABAN, G.A. and RICE, G.P.A., Cytomegalovirus in the brain: in vitro infection of human brain derived cells. J. infect. Dis., 162, 1252-1262 (1990).
17. ROSEN, P.P. and HAJDU, S., Cytomegalovirus inclusion disease at autopsy of patients with cancere. Amer. J. clin. Pathol., 55, 749-756 (1971).
18. ROSENTHAL, L.J. and CHOUDHURY, S., Potential oncogenity of human cytomegalovirus. In: Y. Becker, G. Darai and E.-S. Huang (eds.), Molecular aspects of human cytomegalovirus diseases, Frontiers of virology (vol. 2), pp. 412-436, Springer, Verlag, Berlin (1993).
19. ROSS, R.A., BOSSART, E, SPENGLER, B.A. and BIEDLER, J.L., Multipoint capacity of morphologically intermediate (I-type) human neuroblastoma cells after treatment with differentiation inducing drugs. In: A.E. Evans, G.J. D'Angio, A.G. Knudson, Jr. and R.C. Seeger (eds.), Advances in neuroblastoma research (vol. 3) pp. 193-201, Wiley-Liss, New York (1991).
20. SEEGER, R.C., BRODEUR, G.M., SATHER, H., DALTON, A., SIEGEL, S.E., WONG, K. Y. and HAMMOND, D., Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. New Engl. J. Med., 313, 1111-1116 (1985).
21. SHAPIRO, D.N., HOUGHTON, P.J., HAZELTON, B.J., GERMAIN, G.S., MURTI, K.G., RAHMAN, A. and HOUGHTON, J.A., Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line. Cancer Res., 50, 6002-6009 (1990).
22. SPEIR, E., MODALI, R. HUANG, E.S. LEON, M.B., SHAWL, F., FINKEL,T and EPSTEIN, S.E., Potential role of human cytomegalovirus and p53 interactions in coronary restenosis. Science, 265, 391-394 (1994).
23. ST. JEOR, S. ADMIRALD, J., BRUENING E. and RIOLO, J., Induction of cytokines by human cytomegalovirus. In: S. Michelson and S.A. Plotkin (eds.), Multidisciplinary approach to understanding cytomegalovirus disease, pp. 123-126, Elsevier, Amsterdam (1993).
24. WOLF, D., SINZGER, C., DRESCHER, P., JAHN, G. and PLACHTER, B., Reduced levels of IE2 gene expression and shutdown of early and late viral genes during latent infection of the glioblastoma cell line U138-MG with selectable recombinants of human cytomegalovirus. Virology, 204, 101-113 (1994).